全文获取类型
收费全文 | 20021篇 |
免费 | 915篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 256篇 |
儿科学 | 377篇 |
妇产科学 | 239篇 |
基础医学 | 2477篇 |
口腔科学 | 485篇 |
临床医学 | 1276篇 |
内科学 | 5010篇 |
皮肤病学 | 300篇 |
神经病学 | 1560篇 |
特种医学 | 1012篇 |
外科学 | 3830篇 |
综合类 | 72篇 |
一般理论 | 3篇 |
预防医学 | 478篇 |
眼科学 | 184篇 |
药学 | 1161篇 |
中国医学 | 33篇 |
肿瘤学 | 2299篇 |
出版年
2023年 | 130篇 |
2022年 | 254篇 |
2021年 | 439篇 |
2020年 | 211篇 |
2019年 | 351篇 |
2018年 | 410篇 |
2017年 | 357篇 |
2016年 | 407篇 |
2015年 | 445篇 |
2014年 | 539篇 |
2013年 | 652篇 |
2012年 | 1111篇 |
2011年 | 1160篇 |
2010年 | 707篇 |
2009年 | 592篇 |
2008年 | 1109篇 |
2007年 | 1227篇 |
2006年 | 1184篇 |
2005年 | 1187篇 |
2004年 | 1153篇 |
2003年 | 1094篇 |
2002年 | 1110篇 |
2001年 | 426篇 |
2000年 | 398篇 |
1999年 | 421篇 |
1998年 | 335篇 |
1997年 | 221篇 |
1996年 | 238篇 |
1995年 | 142篇 |
1994年 | 162篇 |
1993年 | 142篇 |
1992年 | 268篇 |
1991年 | 222篇 |
1990年 | 208篇 |
1989年 | 185篇 |
1988年 | 224篇 |
1987年 | 189篇 |
1986年 | 145篇 |
1985年 | 164篇 |
1984年 | 122篇 |
1983年 | 118篇 |
1982年 | 56篇 |
1981年 | 51篇 |
1980年 | 49篇 |
1979年 | 81篇 |
1978年 | 75篇 |
1977年 | 58篇 |
1976年 | 50篇 |
1974年 | 52篇 |
1972年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Takahashi K Muratani T Saito M Ohno N Matsumoto T 《Dermatology (Basel, Switzerland)》2002,204(Z1):59-62
To determine the duration of efficacy of disinfection with povidone-iodine (PVP-I) conducted before application of OpSite Wound (Smith and Nephew, UK), bacteriological evaluation was carried out. In 9 healthy adults, 3 sites on the forearms or other parts were chosen for application of OpSite Wound after adequate disinfection with PVP-I. As compared to the bacterial count score of 1.67-2.00 before disinfection, a significant reduction of the score was observed on removal of OpSite Wound on days 1, 2 and 3. The score of 0.5-0.67 immediately after disinfection did not change or deteriorate until removal of OpSite Wound. This finding supports the fact that unnecessary dressing changes could be avoided postoperatively for at least 3 days by disinfection with PVP-I and application of OpSite Wound particularly for operations categorized as 'clean surgery'. 相似文献
993.
Wakabayashi K Engelender S Tanaka Y Yoshimoto M Mori F Tsuji S Ross CA Takahashi H 《Acta neuropathologica》2002,103(3):209-214
Alpha-synuclein is a major component of Lewy bodies (LB) in Parkinson's disease (PD) and dementia with LB (DLB), as well as of glial cytoplasmic inclusions (GCI) in multiple system atrophy (MSA). Recently, a novel protein called synphilin-1 has been identified that associates with alpha-synuclein, and it has been reported that co-transfection of both alpha-synuclein and synphilin-1 in mammalian cells yielded eosinophilic cytoplasmic inclusions resembling LB. Immunocytochemical and ultrastructural investigations have now been performed on the brain of patients with various neurodegenerative disorders using anti-synphilin-1 antibodies. These antibodies immunostained the neuropil in a punctate pattern throughout the brain of control subjects. In PD, most LB observed in the brain stem were positive for synphilin-1. These LB showed intense staining in their central cores, but their peripheral portions were only weakly stained or unstained. Pale bodies and Lewy neurites, which were positive for alpha-synuclein, were synphilin-1 negative. In DLB, a small fraction of cortical LB were immunolabeled by anti-synphilin-1. In MSA, numerous GCI were positive for synphilin-1. Immunoelectron microscopy revealed that the reaction product was localized within filamentous and circular structures in LB. Various neuronal and glial inclusions in neurodegenerative disorders other than LB disease and MSA were synphilin-1 negative. These findings suggest that abnormal accumulation of synphilin-1 is specific for brain lesions in which alpha-synuclein is a major component. 相似文献
994.
Okada Y Sawa H Endo S Orba Y Umemura T Nishihara H Stan AC Tanaka S Takahashi H Nagashima K 《Acta neuropathologica》2002,104(2):130-136
To examine the function of JC virus (JCV) agnoprotein, we examined the brains of cases of progressive multifocal leukoencephalopathy (PML), which is caused by JCV infection, using a newly generated antibody. The antibody reacted with 8 kDa protein specific for JCV agnoprotein by Western blotting. In vitro analyses showed that JCV capsid protein VP1 and large T antigen (T-Ag) were localized in the nuclei, but that agnoprotein was mainly detected in the cytoplasm of JCV-infected cells with an occasional nuclear staining. In the PML brain, an immunoreactive signal for agnoprotein was distributed in the perinuclear areas and cytoplasmic processes with occasional punctate staining in demyelinating lesions as well as adjacent myelinated areas. Agnoprotein presented mostly in the infected oligodendrocytes and partly in the astrocytes. Using double immunostaining, agnoprotein was seen to be expressed in the cytoplasmic processes of the cells, the nuclei of which were labeled with VP1 and T-Ag, where virus particles existed. Thus, JCV agnoprotein was mostly expressed in the infected oligodendrocytes and mainly localized in the cytoplasmic processes apart from virus particles in the demyelinated lesions. 相似文献
995.
High seizure susceptibility in El mice is associated with disinhibition in the dentate gyrus (DG) and paired-pulse facilitation in the CA3 area in hippocampal slices [Brain Res. 745 (1997) 165; Brain Res. 779 (1998) 324]. A decrease in gamma-aminobutyric acid (GABA)-mediated inhibition and an increase in excitatory inputs to the major neurons seem to be the responsible mechanisms, respectively, for these phenomena. In this study, we examined the effects of tiagabine, an inhibitor of GABA transporter, on hyperexcitation in vivo and in slice preparations. Tiagabine (0.3-0.5 mg/kg) suppressed the occurrence of seizures to about 20% of controls with an ED(50) value of about 0.17 mg/kg. In addition, perfusion of hippocampal slices with tiagabine (20 microM) counteracted the paired-pulse facilitation in the CA3 region over the entire range of interpulse intervals (P<0.05, two-way ANOVA) and reduced the disinhibition in the DG measured at 10 and 20 ms during short interpulse intervals (P<0.005, paired t-test). The CA1 region in the El mice, as well as in a non-epileptic parental strain of ddY mice did not respond to the drug. However, frequency potentiation of CA3 was enhanced in both strains (P<0.05, paired t-test). Our results suggest that within the hippocampus the antiepileptic action of tiagabine is selectively suppressive for hyperexcitability of DG and CA3, which are responsible for seizure-susceptibility in El mice. 相似文献
996.
We have previously reported that the angiotensin system in the anterior hypothalamic area (AHA) is enhanced in spontaneously hypertensive rats (SHR) and that this enhancement is involved in hypertension in SHR. In addition, acetylcholine (ACh) release is increased in the rostral ventrolateral medulla (RVLM) of SHR, which has also been shown to be involved in hypertension in SHR. In this study, we examined whether the enhanced angiotensin system in the AHA of SHR is related to the increase in cholinergic inputs to the RVLM. Electrical stimulation in the AHA produced a pressor response and an increase in firing rate of RVLM barosensitive neurons. These responses were inhibited and enhanced by RVLM application of the muscarinic receptor antagonist scopolamine and the cholinesterase inhibitor physostigmine, respectively. AHA stimulation also produced release of ACh in the RVLM. Microinjections of angiotensin II and carbachol into the AHA produced pressor responses. The pressor response to angiotensin II was inhibited by scopolamine microinjected into the RVLM, although this produced no effect on the response to carbachol. In SHR, although not in Wistar-Kyoto rats, microinjection of losartan into the AHA inhibited pressor responses to physostigmine. However inhibition was not observed in response to the directly acting muscarinic receptor agonist carbachol, injected into the RVLM. These findings demonstrate that angiotensin receptor activation or electrical stimulation in the AHA produce a pressor response via an increase in ACh release in the RVLM. In addition, the present study suggests that the enhanced angiotensin system in the AHA of SHR increases cholinergic inputs to the RVLM, which leads to increases in blood pressure. 相似文献
997.
998.
Kato K Wada T Kawakatsu S Otani K 《Progress in neuro-psychopharmacology & biological psychiatry》2002,26(1):201-203
A 69-year-old female of dementia with Lewy bodies (DLB) with fluctuating cognitive impairment, visual and auditory hallucinations, persecutory delusions and Parkinsonism was treated by the combination of 1 mg/day risperidone and 300-750 mg/day L-DOPA. By this combination therapy, both the psychotic symptoms and Parkinsonism improved, while cognitive function did not deteriorate. This report suggests that the combination therapy of risperidone and L-DOPA may be worth considering in the special cases of DLB. 相似文献
999.
Sato K Yoshida K Takahashi H Ito K Kamata M Higuchi H Shimizu T Itoh K Inoue K Tezuka T Suzuki T Ohkubo T Sugawara K Otani K 《Neuropsychobiology》2002,46(3):136-140
Genetic polymorphism of the serotonin 5-HT(2A) receptor seems to be associated with therapeutic response to selective serotonin reuptake inhibitors (SSRIs). The present study investigated whether a novel -1438G/A polymorphism in the promoter region of the 5-HT(2A )receptor gene is associated with therapeutic response to fluvoxamine (an SSRI) in 66 Japanese patients with major depressive disorder. Fluvoxamine (50 to 200 mg) was administered twice daily for 6 weeks. Fifty-four patients completed this study. The genotype distribution and the allele frequencies showed no significant difference between responders and non-responders. The time-course of the Montgomery-Asberg Depression Rating Scale scores showed no significant difference among -1438G/G, -1438G/A, and -1438A/A genotype groups. The results demonstrated that the -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene was unlikely to have a major role in therapeutic response to fluvoxamine in Japanese patients with major depressive disorder. 相似文献
1000.
Nomura K Miyagawa S Ayukawa K Soeda J Taniguchi S Kawasaki S 《Journal of hepatology》2002,36(5):637-644